Xolair Allergic Asthma Population Should Not Be Restricted Except By Age
Genentech/Novartis' Xolair allergic asthma patient population should not be restricted except by age, FDA's Pulmonary-Allergy Drugs Advisory Committee recommended May 15
Genentech/Novartis' Xolair allergic asthma patient population should not be restricted except by age, FDA's Pulmonary-Allergy Drugs Advisory Committee recommended May 15